PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 153 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2016. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $13,071,000 | -64.8% | 285,091 | -54.5% | 1.41% | -1.9% |
| Q2 2018 | $37,084,000 | +29.1% | 626,950 | +48.6% | 1.43% | +25.9% |
| Q1 2018 | $28,715,000 | +228.5% | 421,966 | +322.0% | 1.14% | +578.0% |
| Q2 2017 | $8,740,000 | -48.5% | 100,000 | -78.1% | 0.17% | -61.6% |
| Q1 2017 | $16,967,000 | +23.2% | 456,097 | +1.7% | 0.44% | +64.9% |
| Q4 2016 | $13,768,000 | -21.3% | 448,471 | -23.6% | 0.26% | -24.3% |
| Q2 2016 | $17,490,000 | +319.8% | 587,126 | +1367.8% | 0.35% | +79.5% |
| Q1 2014 | $4,166,000 | – | 40,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,417,000 | $18,010,000 | 2.24% |
| Palo Alto Investors LP | 1,405,680 | $17,866,000 | 0.87% |
| PFM Health Sciences, LP | 2,838,376 | $36,076,000 | 0.68% |
| TANG CAPITAL MANAGEMENT LLC | 349,400 | $4,441,000 | 0.60% |
| Capital Impact Advisors, LLC | 127,029 | $1,615,000 | 0.59% |
| Leap Investments LP | 29,100 | $370,000 | 0.50% |
| Spark Investment Management LLC | 454,300 | $5,774,000 | 0.40% |
| Partner Investment Management, L.P. | 27,567 | $350,000 | 0.37% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 262,945 | $3,342,000 | 0.26% |
| Rock Springs Capital Management LP | 534,400 | $6,792,000 | 0.25% |